Authors

Sreenija Yarlagadda, Miami Cancer InstituteFollow
Rob Rohe, Miami Cancer InstituteFollow
Val McNeill, Miami Cancer InstituteFollow
Joanna Nemec, Miami Cancer InstituteFollow
Chelsea Tohtz, Miami Cancer InstituteFollow
Nicole McAllister, Miami Cancer InstituteFollow
Amy Rzepczynski, Miami Cancer InstituteFollow
Kristen McConnell, Miami Cancer InstituteFollow
Noah Kalman, Miami Cancer InstituteFollow
Zachary Fellows, Miami Cancer Institute

Tubarial gland sparing for oropharyngeal cancer: Feasibility with intensity modulated proton therapy & intensity modulated radiation therapy

Publication Date

6-1-2025

Content Type

Article

PubMed ID:

40194703

Citation

Yarlagadda, S., Rohe, R. M., McNeill, V., Nemec, J. R., Tohtz, C. P., Fellows, Z. W., McAllister, N., Rzepczynski, A. E., McConnell, K. A., & Kalman, N. S. (2025). Tubarial gland sparing for oropharyngeal cancer: Feasibility with intensity modulated proton therapy & intensity modulated radiation therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 207, 110882. https://doi.org/10.1016/j.radonc.2025.110882